Total revenues for Q2'17 were $7.8 million, down 24% from the second quarter of last year. This decrease in revenue was attributable to the expiration of Edible Garden's contract with a grower of floral products, partially offset by growth in the company's cannabis segment. Revenues in Terra Tech's cannabis segment increased 57.9% on higher sales at the company's Blüm dispensary in Oakland, California, sales from the Company's four Nevada-based Blüm Dispensaries and sales of IVXX cannabis products.
Terra Tech generated approximately $1.5 million of gross profit in the second quarter of 2017. Gross margin in Q2'17 was approximately 19%, up from approximately 16% in the second quarter of 2016. The improvement in gross margin was attributable to the expiration of the floral product contract at Edible Garden, partially offset by a decline in margins at the company's cannabis segment due to discounts.
In Q2'17, selling, general and administrative expenses increased to $6.0 million from $5.4 million in the second quarter of 2016. The increase was primarily attributable to an increase in salary expenses related to hiring at the company's Blüm locations as well as higher accounting and compliance costs.
Net losses in Q2'17 were approximately $0.5 million, or $0.00 per share, compared to net losses of $4.9 million, or $0.01 per share for the quarter ended June 30, 2016.
As of June 30, 2017, the company had $9.1 million in cash and cash equivalents.
Terra Tech received provisional permits for both its San Leandro, CA dispensary and production facility and its Oakland, CA cultivation facility. The company expects both facilities to be fully operational in the fourth quarter of 2017.
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.